Drreddys Laboratories | RDY - Le Chiffre D'Affaires De Vente





Ventes Changement Date
ANI Pharmaceuticals USD 266M 28.5M 2026-06
Aurora Cannabis CAD 38.01M 56.18M 2026-03
Bayer EUR 10.87B 2.54B 2026-06
Canopy Growth CAD 71.25M 3.29M 2026-03
Cipla INR 71.19B 5.78B 2026-06
Corcept Therapeutics USD 256.15M 91.25M 2026-06
Drreddys Laboratories INR 789.05M 86.48B 2026-03
GlaxoSmithKline GBP 8.41B 781M 2026-06
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lonza CHF 3.58B 63M 2025-06
Novartis USD 14.41B 1.3B 2026-06
Pacira USD 192.4M 15.4M 2026-06
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 265.71M 15.91M 2026-06
Richter Gedeon HUF 220.2B 5.51B 2026-03
Sun Pharmaceuticals INR 153B 7.14B 2026-06
Supernus Pharmaceuticals USD 219.1M 11.39M 2026-06
Teva Pharmaceutical Industries USD 12.67B 900M 2026-06